Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The 2010 joint session between the ESC and the European Stroke Conference was a great success of attendance and interest.
The genetic aspects of A Fib were treated very clinically by Dr. Holm. She underlined the importance of some genes in selecting patients at higher risk of recurrences after AF ablation and the occurrence of AF in patents undergoing bypass surgery. We really need another risk factor for developing AF, independent of the usual clinical ones (ischemia, hypertension, diabetes, etc).
The great clinical interest in new anticoagulants was clear to all the attendees in the presentation of Dr. Diener. He underlined the importance of Dabigatran and of the upcoming results of other new oral anticoagulants in substituting warfarin for millions of patients with AF. Among so many important points, a wise suggestion was to use anticoagulants looking at the risk/benefit ratio: an intracranial haemorrhage is definitively a much heavier event than most small ischemic stroke and TIA.
The cathether ablation of AF is an important procedure, often curative for AF patients. Dr Arnar extensively described importance and limitations of ablation. He underlined the importance of selecting the right patient for this procedure: look always for the extent of AF symptoms and the percentage of success / complications of AF ablation.
The greatest moment of cardiologist / neurologist interaction came out of the presentation of Prof. M Hennerici, President of the European Stroke Conference. He superbly illustrated the new ASCO classification of stroke, which completely overcomes the great limitations of the previous TOAST one. He showed its importance in guiding the best therapy in stroke patients, who are very often affected simultaneously by more than one aetiological cause of stroke.
This interaction between associations will help to develop schematics for which exams are necessary and what is the best order in which to perform them in different patients, according to their pathologies: joint recommendations for cardiologists and neurologists are really needed in the light of all the news presented in this symposium.
© 2017 European Society of Cardiology. All rights reserved